Onconetix Inc — Cash Flow (NASDAQ:ONCO) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics

Quarterly Annual

Cash from operating activities -8.7 M-13.58 M10.5 M-9.68 M -9.68 M Cash from investing activities -9 339-8.65 M-28.47 K0 0 Cash from financing activities 32.53 M1.04 M6.74 M14.45 M 14.45 M Free cash flow -8.71 M-7.58 M10.47 M-9.68 M -9.68 M

ニュース

Morning News Wrap-Up: 3/27/26: Today’s Biggest Stock Market Stories - TipRanks.com

What's Going On With Onconetix Shares On Friday? - Onconetix (NASDAQ:ONCO)

Onconetix, Inc. (ONCO) M&A Call Transcript

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.34%

オンコペプチド、2025年第3四半期：売上高174%増、2026年に収益性達成を目標

Oncopeptides Q3 2025 slides: Revenue surges 174% as profitability target set for 2026

オンコペプチデス、2025年第3四半期決算発表で売上高174%増

Earnings call transcript: Oncopeptides Q3 2025 reveals 174% sales surge

Enzymatica、新CFOにホルガー・レンブレールを任命

Enzymatica appoints Holger Lembrér as new CFO

Veru社、Onconetix社との88万ドルの債務を現金、優先株式、ワラントで清算

オンコネティクス、プライベートプレースメントで1290万ドルを調達